BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22086150)

  • 1. Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.
    de Krijger RR; Papathomas TG
    Virchows Arch; 2012 Jan; 460(1):9-18. PubMed ID: 22086150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in surgical pathology of adrenocortical tumours.
    Erickson LA
    Histopathology; 2018 Jan; 72(1):82-96. PubMed ID: 29239032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncocytic adrenocortical carcinoma: a rare adrenal tumor subtype.
    Sumner E; Acar BC; Acker MR
    Can J Urol; 2017 Jun; 24(3):8865-8867. PubMed ID: 28646944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adrenocortical tumors with oncocytic cells: benign or malignant?].
    Icard P; Louvel A; Le Charpentier M; Chapuis Y
    Ann Chir; 2001 Apr; 126(3):249-53. PubMed ID: 11340712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma.
    Duregon E; Volante M; Rapa I; Vatrano S; Papotti M
    Turk Patoloji Derg; 2015; 31 Suppl 1():98-104. PubMed ID: 26177320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
    Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
    J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of oncocytic adrenocortical carcinoma clinically presented as an incidentaloma.
    Harada K; Yasuda M; Nakano Y; Yoshida K; Umeda Y; Yagi T; Yamazaki Y; Sasano H; Otsuka F
    Endocr J; 2020 Aug; 67(8):883-888. PubMed ID: 32249250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
    Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
    Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
    Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
    Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Diagnostic Approach to Adrenocortical Tumors.
    Hodgson A; Pakbaz S; Mete O
    Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current criteria for the diagnosis of adrenocortical carcinoma].
    Selivanova LS; Roslyakova AA; Kovalenko YA; Bogolyubova AV; Tertychnyi AS; Beltsevich DG; Abrosimov AY; Melnichenko GA
    Arkh Patol; 2019; 81(3):66-73. PubMed ID: 31317933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
    Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
    Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adrenocortical cancer: morphological variants, immunohistochemical characteristics].
    Tkachuk AV; Tertychnyi AS; Beltsevich DG; Roslyakova AA; Belousov PV; Selivanova LS
    Arkh Patol; 2021; 83(3):10-18. PubMed ID: 33822549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
    Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
    Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mimic of sarcomatoid adrenal cortical carcinoma: epithelioid angiosarcoma occurring in adrenal cortical adenoma.
    Hayashi T; Gucer H; Mete O
    Endocr Pathol; 2014 Dec; 25(4):404-9. PubMed ID: 25246132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic Features of Adrenal Cortical Carcinoma.
    Gambella A; Volante M; Papotti M
    Adv Anat Pathol; 2023 Jan; 30(1):34-46. PubMed ID: 36084635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical oncocytic carcinoma misdiagnosed as adrenal cortical adenoma.
    Li Y; Li P; Tao FK; Li JM
    Asian J Surg; 2024 May; 47(5):2475-2476. PubMed ID: 38302362
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
    Sasano H; Suzuki T; Moriya T
    Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxoid variant of adrenocortical carcinoma: report of a unique case.
    Karim RZ; Wills EJ; McCarthy SW; Scolyer RA
    Pathol Int; 2006 Feb; 56(2):89-94. PubMed ID: 16445821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Oncocytic Adrenal Cortical Neoplasm with Uncertain Malignant Potential Turned Out to Be Oncocytic Adrenal Cortical Carcinoma with Distant Metastasis: Could Pathology Do Better Initially?
    Huang CP; Dai MS; Kao CC; Tsai WC; Yu CP
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.